Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1981-7-23
pubmed:abstractText
1. The ability of a range of phenothiazines to inhibit activation of brain phosphodiesterase by purified calmodulin was studied. Trifluoperazine, prochlorperazine and 8-hydroxyprochlorperazine produced equipotent dose-dependent inhibition with half-maximum inhibition at 12mum. When tested at 10 or 50mum, 7-hydroxyprochlorperazine was a similarly potent inhibitor. However, trifluoperazine-5-oxide and N-methyl-2-(trifluoromethyl)phenothiazine were ineffective at concentrations up to 50mum, and produced only a modest inhibition at 100mum. 2. The same phenothiazines were tested for their ability to inhibit activation of brain phosphodiesterase by boiled extracts of rat islets of Langerhans. At a concentration of 20mum, 70-80% inhibition was observed with trifluoperazine, prochlorperazine, 7-hydroxyprochlorperazine or 8-hydroxyprochlorperazine, whereas trifluoperazine-5-oxide and N-methyl-2-(trifluoromethyl)phenothiazine were less effective. 3. The effect of these phenothiazines on insulin release from pancreatic islets was studied in batch-type incubations. Insulin release stimulated by glucose (20mm) was markedly inhibited by 10mum-trifluoperazine or -prochlorperazine and further inhibited at a concentration of 20mum. 8-Hydroxyprochlorperazine (20mum) was also a potent inhibitor but 7-hydroxyprochlorperazine (20mum) elicited only a modest inhibition of glucose-stimulated insulin release; no inhibition was observed with trifluoperazine-5-oxide or N-methyl-2-(trifluoromethyl)phenothiazine. 4. Trifluoperazine (20mum) markedly inhibited insulin release stimulated by leucine or 4-methyl-2-oxopentanoate in the absence of glucose, and both trifluoperazine and prochlorperazine (20mum) decreased insulin release stimulated by glibenclamide in the presence of 3.3mm-glucose. 5. None of the phenothiazines affected basal insulin release in the presence of 2mm-glucose. 6. Trifluoperazine (20mum) did not inhibit islet glucose utilization nor the incorporation of [(3)H]leucine into (pro)insulin or total islet protein. 7. Islet extracts catalysed the incorporation of (32)P from [gamma-(32)P]ATP into endogenous protein substrates. Sodium dodecyl sulphate/polyacrylamide-gel electrophoresis resolved several phosphorylated bands, but incorporation was slight. However, calmodulin in the presence of Ca(2+) greatly enhanced incorporation: the predominant phosphorylated band had an estimated mol.wt. of 55000. This enhanced incorporation was abolished by trifluoperazine, but not by cyclic AMP-dependent protein kinase inhibitor protein. 8. These results suggest that islet phosphodiesterase-stimulating activity is similar to, although not necessarily identical with, calmodulin from skeletal muscle; that islet calmodulin may play an important role in Ca(2+)-dependent stimulus-secretion coupling in the beta-cell; and that calmodulin may exert part at least of its effect on secretion via phosphorylation of endogenous islet proteins.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-1205021, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-165665, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-170936, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-18661, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-197955, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-201280, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-211505, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-212300, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-214787, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-218093, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-225798, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-226067, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-226410, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-27079, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-287024, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-357989, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-361036, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-4199014, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-4313804, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-4315350, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-4342607, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-4591650, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-5967794, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-6245006, http://linkedlifedata.com/resource/pubmed/commentcorrection/6263264-6246114
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
192
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
919-27
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1980
pubmed:articleTitle
Evidence for the participation of calmodulin in stimulus-secretion coupling in the pancreatic beta-cell.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't